Parkinson's Disease
Annovis Bio Achieves 85% Enrollment in Phase 3 Alzheimer’s Trial, Advances Parkinson’s Program
Annovis Bio reports first-quarter progress with 85% enrollment in its pivotal Phase 3 Alzheimer's trial and 40% enrollment in its Parkinson's open-label study, signaling potential regulatory milestones for buntanetap.
Annovis Bio Inc. to Host Webcast on Alzheimer’s and Parkinson’s Programs Updates
Annovis Bio Inc. (NYSE: ANVS) is set to host a webcast featuring CEO Maria Maccecchini, Ph.D., to discuss updates on its Phase 3 trial for early Alzheimer’s disease and FDA feedback on its Parkinson’s disease program, highlighting the company's progress in neurodegenerative disease treatments.
Innovative Animated Documentary 'Living with A Visionary' Explores Parkinson's Through Unique Visual Storytelling
Garden Shed Productions is creating an innovative animated documentary short that transforms a poignant memoir about caregiving and Parkinson's into a groundbreaking hand-animated film, utilizing specialized watercolor techniques to capture the emotional complexity of memory and hallucination.